Repligen Corporation to Present at Upcoming September Conferences
Repligen Corporation (NASDAQ:RGEN), a bioprocessing technology leader in life sciences, has announced its participation in three major healthcare conferences in September 2025:
- Wells Fargo Healthcare Conference (Sept 3-5, Boston) - CEO Olivier Loeillot to join analyst discussion on Sept 4 at 8:00 a.m. ET
- Deutsche Bank Healthcare Summit (Sept 10-11, NYC) - CFO Jason Garland to hold 1x1 meetings on Sept 10
- Bank of America Global Healthcare Conference (Sept 23-25, London) - CEO Olivier Loeillot to participate in analyst discussion on Sept 25 at 6:35 a.m. ET
Live webcasts will be available on Repligen's Investor Relations website with limited-time replay access.
Repligen Corporation (NASDAQ:RGEN), leader nelle tecnologie per il bioprocesso nel settore delle scienze della vita, ha annunciato la propria partecipazione a tre importanti conferenze sanitarie a settembre 2025:
- Wells Fargo Healthcare Conference (3-5 settembre, Boston) - l'Amministratore Delegato Olivier Loeillot parteciper脿 a una discussione con gli analisti il 4 settembre alle 8:00 ET
- Deutsche Bank Healthcare Summit (10-11 settembre, New York) - il Direttore Finanziario Jason Garland terr脿 incontri one-to-one il 10 settembre
- Bank of America Global Healthcare Conference (23-25 settembre, Londra) - l'Amministratore Delegato Olivier Loeillot interverr脿 in una discussione con gli analisti il 25 settembre alle 6:35 ET
I webcast in diretta saranno disponibili sul sito Investor Relations di Repligen con replay accessibile per un periodo limitato.
Repligen Corporation (NASDAQ:RGEN), l铆der en tecnolog铆a de bioprocesos en ciencias de la vida, ha anunciado su participaci贸n en tres importantes conferencias sanitarias en septiembre de 2025:
- Wells Fargo Healthcare Conference (3-5 de septiembre, Boston) - el CEO Olivier Loeillot participar谩 en una sesi贸n con analistas el 4 de septiembre a las 8:00 ET
- Deutsche Bank Healthcare Summit (10-11 de septiembre, Nueva York) - el CFO Jason Garland realizar谩 reuniones 1 a 1 el 10 de septiembre
- Bank of America Global Healthcare Conference (23-25 de septiembre, Londres) - el CEO Olivier Loeillot participar谩 en una sesi贸n con analistas el 25 de septiembre a las 6:35 ET
Se podr谩n ver retransmisiones en directo en la web de Investor Relations de Repligen, con acceso a la repetici贸n por tiempo limitado.
Repligen Corporation (NASDAQ:RGEN), 靸濍獏瓿柬暀 攵勳暭鞚� 氚旍澊鞓ろ攧搿滌劯鞀� 旮办垹 靹犽弰旮办梾鞚� 2025雲� 9鞗旍棎 鞐措Μ電� 靹� 瓿踌潣 欤检殧 項姢旒�鞏� 旖橅嵓霟办姢鞐� 彀戈皜頃滊嫟瓿� 氚滍憸頄堨姷雼堧嫟:
- Wells Fargo Healthcare Conference (9鞗� 3鈥�5鞚�, 氤挫姢韯�) - CEO Olivier Loeillot臧� 9鞗� 4鞚� 鞓れ爠 8:00(ET)鞐� 鞎犽剱毽姢韸� 韺剱鞐� 彀胳劃
- Deutsche Bank Healthcare Summit (9鞗� 10鈥�11鞚�, 雺挫殨) - CFO Jason Garland臧� 9鞗� 10鞚� 鞚茧寑鞚� 氙疙寘 歆勴枆
- Bank of America Global Healthcare Conference (9鞗� 23鈥�25鞚�, 霟半崢) - CEO Olivier Loeillot臧� 9鞗� 25鞚� 鞓れ爠 6:35(ET)鞐� 鞎犽剱毽姢韸� 韺剱鞐� 彀胳棳
霛检澊敫� 鞗轨簮鞀ろ姼電� Repligen 韴瀽鞛� 甏�瓿� 鞗轨偓鞚错姼鞐愳劀 鞝滉车霅橂┌, 頃滌嫓鞝� 鞛癌靻� 鞚挫毄鞚� 臧�電ロ暕雼堧嫟.
Repligen Corporation (NASDAQ:RGEN), leader des technologies de bioproc茅d茅s en sciences de la vie, a annonc茅 sa participation 脿 trois conf茅rences majeures du secteur de la sant茅 en septembre 2025 :
- Wells Fargo Healthcare Conference (3-5 septembre, Boston) - le PDG Olivier Loeillot participera 脿 une discussion avec des analystes le 4 septembre 脿 8h00 ET
- Deutsche Bank Healthcare Summit (10-11 septembre, New York) - le directeur financier Jason Garland tiendra des r茅unions individuelles le 10 septembre
- Bank of America Global Healthcare Conference (23-25 septembre, Londres) - le PDG Olivier Loeillot participera 脿 une discussion avec des analystes le 25 septembre 脿 6h35 ET
Des webcasts en direct seront disponibles sur le site Investor Relations de Repligen, avec un acc猫s aux replays pendant une dur茅e limit茅e.
Repligen Corporation (NASDAQ:RGEN), ein f眉hrendes Unternehmen f眉r Bioprozess-Technologie in den Lebenswissenschaften, hat seine Teilnahme an drei wichtigen Healthcare-Konferenzen im September 2025 angek眉ndigt:
- Wells Fargo Healthcare Conference (3.鈥�5. September, Boston) - CEO Olivier Loeillot nimmt am 4. September um 8:00 Uhr ET an einer Analystendiskussion teil
- Deutsche Bank Healthcare Summit (10.鈥�11. September, New York) - CFO Jason Garland f眉hrt am 10. September Einzelgespr盲che
- Bank of America Global Healthcare Conference (23.鈥�25. September, London) - CEO Olivier Loeillot nimmt am 25. September um 6:35 Uhr ET an einer Analystendiskussion teil
Live-Webcasts sind auf der Investor-Relations-Website von Repligen verf眉gbar; Replays sind f眉r begrenzte Zeit abrufbar.
- None.
- None.
WALTHAM, Mass., Aug. 22, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be attending three upcoming investor conferences.
- The Wells Fargo Healthcare Conference, being held September 3 鈥� 5 in Boston. Olivier Loeillot, President and Chief Executive Officer, will participate in an analyst led discussion at 8:00 a.m. ET on Thursday, September 4, 2025.
- The Deutsche Bank Healthcare Summit, being held September 10 鈥� 11 in New York. Jason Garland, Chief Financial Officer, will participate in 1x1 meetings on September 10.
- The Bank of America Global Healthcare Conference, being held September 23 鈥� 25 in London, UK. Olivier Loeillot, President and Chief Executive Officer, will participate in an analyst led discussion at 6:35 a.m. ET/11:35 a.m. British Summer Time on Thursday, September 25, 2025.
A live webcast of the conference presentations will be accessible through Repligen鈥檚听 website at , and will be available for replay for a limited period of time following the event.
About Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs. We are 鈥渋nspiring advances in bioprocessing鈥� for the customers we serve; primarily biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide. Our focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins. Our corporate headquarters are located in Waltham, Massachusetts, and the majority of our manufacturing sites are in the U.S., with additional key sites in Estonia, France, Germany, Ireland, the Netherlands and Sweden. For more information about the our company see our website at , and follow us on .
Repligen Contact:
Jacob Johnson
VP, Investor Relations
781-419-0204
听
FAQ
When is Repligen (NASDAQ:RGEN) presenting at the Wells Fargo Healthcare Conference 2025?
Who will represent Repligen at the Deutsche Bank Healthcare Summit 2025?
What time is Repligen's presentation at the Bank of America Global Healthcare Conference 2025?
How can investors access Repligen's conference presentations?
